More research is also needed to advance the repurposing of old antimicrobials, improving their activity and to develop new combination therapies, including those to treat multidrug resistant tuberculosis (MDR-TB).
Rohkem teadusuuringuid on vaja ka selleks, et edendada vanade antimikroobikumide otstarbe muutmist, parandades nende toimet, ja töötada välja uusi ravikombinatsioone, sealhulgas multiresistentse tuberkuloosi ravimiseks.